A critical advance in cancer study is arising with the use of nanobodies to re-engage mutated p53. This vital tumor protector protein is frequently disabled in many types of tumors, leading uncontrolled body division. https://bookmarkextent.com/story24147451/mini-antibodies-reactivate-p53-the-potential-hope-for-malignant-therapy